VillageMD raised $100 Million in Series B funding, led by Kinnevik with a return investment from Oak HC/FT and additional investments from Town Hall Ventures and Adams Street Partners.
Tim Barry, Chief Executive Officer and co-founder of VillageMD, said that the funding will allow VillageMD to scale in existing and new markets. “Partnering with these world-class investors, who share our vision and bring us fresh capital and new capabilities, allows us to impact more patients and ultimately improve the quality of care in our country,” said Barry.
In April, VillageMD announced that it has partnered with drugstore giant Walgreens to build primary care clinics in Houston.
To read this article from the Wall Street Journal, click here.